To substantiate the role of DUSP16 in the regulation of cancer cell sensitivity to platinum-based chemotherapy, we examined a cohort of breast cancer patients who were treated with platinum-based drugs including cisplatin, carboplatin, and lobaplatin after surgery. Here, DUSP16 is linked to breast cancer.